# Filing Detail

Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-14-157375
Filing Date
2014-04-24
Accepted
2014-04-24 17:17:43
Documents
3
Period of Report
2014-05-27
Effectiveness Date
2014-04-24

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | DEFINITIVE PROXY STATEMENT | d700350ddef14a.htm | DEF 14A | 634806
2 | GRAPHIC | g700350pc_pg001.jpg | GRAPHIC | 300682
3 | GRAPHIC | g700350pc_pg002.jpg | GRAPHIC | 193515
| Complete submission text file | 0001193125-14-157375.txt |  | 1317258

Mailing Address 123 SAGINAW DRIVE 123 SAGINAW DRIVE REDWOOD CITY CA 94063
Business Address 123 SAGINAW DRIVE REDWOOD CITY CA 94063 6503662626
HERON THERAPEUTICS, INC. /DE/ (Filer) CIK: 0000818033 (see all company filings)

EIN.: 942875566 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-33221 | Film No.: 14782472
SIC: 2834 Pharmaceutical Preparations